Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10742366 | Journal of Geriatric Oncology | 2015 | 9 Pages |
Abstract
The SarcoPRO was moderately associated with the SPPB, an objective measure of physical performance, and was associated with limitations in IADLs. Thus, older patients with cancer who present with IADL limitations should be screened for sarcopenia. The SarcoPRO shows promise as a measure for screening as well as outcome assessment for research on sarcopenia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Jennifer S. Gewandter, William Dale, Allison Magnuson, Chintan Pandya, Charles E. Heckler, Tatyana Lemelman, Breton Roussel, Rafa Ifthikhar, James Dolan, Katia Noyes, Supriya G. Mohile,